The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 38, No. 1, pp. 15-19. DOI 10.1345/aph.1D052
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garrison, G. D.
Right arrow Articles by Miller, M. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garrison, G. D.
Right arrow Articles by Miller, M. M

INFECTIOUS DISEASES

High-Dose Versus Standard-Dose Amoxicillin for Acute Otitis Media

Gina Daubney Garrison, PharmD

Assistant Professor, Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY

Paul C Sorum, MD

Professor, Departments of Medicine and Pediatrics, Albany Medical Center, Albany

Wayne Hioe, MD

Consulting Staff, Departments of Medicine and Pediatrics, Cherokee Indian Hospital, Cherokee, NC

Margaret M Miller, PhD

Independent Research Consultant, Denver, CO

Reprints: Gina Daubney Garrison PharmD, Department of Pharmacy Practice, Albany College of Pharmacy, 106 New Scotland Ave., Albany, NY 12208-3492, fax 518/445-7302, garrisog{at}acp.edu

BACKGROUND: Emergence of drug-resistant bacteria has led to a recommendation to use high-dose (HD) amoxicillin (80-90 mg/kg/d) rather than standard-dose (SD) amoxicillin (40-45 mg/kg/d) to treat children with acute otitis media (AOM).

OBJECTIVE: To compare the efficacy and tolerability of HD versus SD amoxicillin among children with AOM who were considered at low risk for infection with antibiotic-resistant bacteria.

METHODS: A double-blind, randomized, 3-year clinical trial was conducted using participants who met the following criteria: age >3 mo, weight <=18 kg, diagnosed with AOM, and candidates for treatment with amoxicillin. The primary endpoint was treatment success at a 3- to 4-day follow-up visit based on the clinical decision to continue the prescribed antibiotic therapy for AOM. Other endpoints included duration of illness, number of office visits and telephone calls related to illness, total number of subsequent AOM episodes, and number of adverse effects.

RESULTS: The absolute difference in antibiotic failure rate with SD versus HD amoxicillin at the follow-up visit was nonsignificant (95% CI -1.5% to 3.4%; p = 0.78). The mean duration of illness was similar for both doses of amoxicillin (3 ± 2 d). The number of office visits and telephone calls related to illness and the number of subsequent AOM episodes did not differ between the 2 treatment groups. HD amoxicillin did not result in a greater incidence of adverse effects than SD amoxicillin.

CONCLUSIONS: HD amoxicillin had neither benefit nor detriment compared with SD for AOM in children at low risk for infection with antibiotic-resistant bacteria.

Key Words: acute otitis media, amoxicillin, antibiotic resistance, children

Published Online, November 25, 2003. www.theannals.com, DOI 10.1345/aph.1D052


This article has been cited by other articles:


Home page
CLIN PEDIATRHome page
S. M. Chandler, S. M. S. Garcia, and D. P. McCormick
Consistency of Diagnostic Criteria for Acute Otitis Media: A Review of the Recent Literature
Clinical Pediatrics, March 1, 2007; 46(2): 99 - 108.
[Abstract] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. Erramouspe and P. S Cady
What is Optimal for Antibiotic Studies in Acute Otitis Media?
Ann. Pharmacother., January 1, 2004; 38(1): 158 - 160.
[Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.